Development of macrolide resistance in Mycoplasma pneumoniae-infected Swedish patients treated with macrolides

References

• Foy HM, Kenny GE, McMahan R, Kaiser G, Grayston JT. Mycoplasma pneumoniae in the community. Am J Epidemiol 1971;93:55–67.
   PubMed Web of Science ®Google Scholar
• Lind K, Benzon MW, Jensen JS, Clyde WA Jr. A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946–95. Eur J Epidemiol 1997l;13:581–6.
   PubMed Web of Science ®Google Scholar
• Nilsson AC, Bjorkman P, Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol 2008;8:93.
   PubMed Web of Science ®Google Scholar
• Taylor-Robinson D, Bebear C. Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections. J Antimicrob Chemother 1997;40:622–30.
   PubMed Web of Science ®Google Scholar
• Morozumi M, Takahashi T, Ubukata K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother 2010;16:78–86.
   PubMed Web of Science ®Google Scholar
• Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis 2010; 2:189–94.
   Google Scholar
• Cardinale F, Chironna M, Chinellato I, Principi N, Esposito S. Clinical relevance of Mycoplasma pneumoniae macrolide resistance in children. J Clin Microbiol 2013; 51:723–4.
   PubMed Web of Science ®Google Scholar
• Principi N, Esposito S. Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection. J Antimicrob Chemother 2013;68:506–11.
   PubMed Web of Science ®Google Scholar
• Okazaki N, Ohya H, Sasaki T. Mycoplasma pneumoniae isolated from patients with respiratory infection in Kanagawa Prefecture in 1976–2006: emergence of macrolide-resistant strains. Jpn J Infect Dis 2007;60:325–6.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ye X, Zhang H, Xu X, Li W, Zhu D, et al. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China. Antimicrob Agents Chemother 2009; 53:2160–2.
   PubMed Web of Science ®Google Scholar
• Zhao F, Lv M, Tao X, Huang H, Zhang B, Zhang Z, et al. Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China. Antimicrob Agents Chemother 2012; 56:1108–9.
   PubMed Web of Science ®Google Scholar
• Uldum SA, Bangsborg JM, Gahrn-Hansen B, Ljung R, Mølvadgaard M, Føns Petersen R, et al. Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill 2012; 2:17.
   Google Scholar
• Spuesens EB, Meijer A, Bierschenk D, Hoogenboezem T, Donker GA, Hartwig NG, et al. Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in the Netherlands. J Clin Microbiol 2012; 50:1999–2004.
   PubMed Web of Science ®Google Scholar
• Dumke R, von Baum H, Luck PC, Jacobs E. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect 2010;6:613–6.
   Google Scholar
• Yamada M, Buller R, Bledsoe S, Storch GA. Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States. Pediatr Infect Dis J 2012;4:409–10.
   Google Scholar
• Chironna M, Sallustio A, Esposito S, Perulli M, Chinellato I, Di Bari C, et al. Emergence of macrolide- resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother 2011; 66:734–7.
   PubMed Web of Science ®Google Scholar
• Foy HM, Kenny GE, Cooney MK, Allan ID. Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis 1979;139:681–7.
   PubMed Web of Science ®Google Scholar
• Smith CB, Friedewald WT, Chanock RM. Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin therapy. N Engl J Med 1967;276:1172–5.
   PubMed Web of Science ®Google Scholar
• Nilsson AC, Bjorkman P, Welinder-Olsson C, Widell A, Persson K. Clinical severity of Mycoplasma pneumoniae (MP) infection is associated with bacterial load in oropharyngeal secretions but not with MP genotype. BMC Infect Dis 2010;10:39.
   PubMed Web of Science ®Google Scholar
• Jensen JS, Bradshaw CS, Tabrizi SN, Fairley CK, Hamasuna R. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 2008; 47:1546–53.
   PubMed Web of Science ®Google Scholar
• Bradshaw CS, Jensen JS, Tabrizi SN, Read TR, Garland SM, Hopkins CA, et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis 2006;12:1149–52.
   PubMed Web of Science ®Google Scholar
• Cardinale F, Chironna M, Dumke R, Binetti A, Daleno C, Sallustio A, et al. Macrolide- resistant Mycoplasma pneumoniae in paediatric pneumonia. Eur Respir J 2011; 37:1522–4.
   PubMed Web of Science ®Google Scholar
• Kawai Y, Miyashita N, Yamaguchi T, Saitoh A, Kondoh E, Fujimoto H, et al. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients. Respirology 2012;17:354–62.
   PubMedGoogle Scholar
• Akaike H, Miyashita N, Kubo M, Kawai Y, Tanaka T, Ogita S, et al. In vitro activities of 11 antimicrobial agents against macrolide-resistant Mycoplasma pneumoniae isolates from pediatric patients: results from a multicenter surveillance study. Jpn J Infect Dis 2012;65:535–8.
   PubMedGoogle Scholar